EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY-NC 4.0

A comparison of the epidemiology of kidney replacement therapy between Europe and the United States: 2021 data of the ERA Registry and the USRDS

Vianda S Stel, Rianne Boenink, Megan E Astley, Brittany A Boerstra iD, Danilo Radunovic, Rannveig Skrunes, Juan C Ruiz San Millán, Maria F Slon Roblero, Samira Bell, Pablo Ucio Mingo, Marc A G J Ten Dam, Patrice M Ambühl und 18 weitere

Nephrology Dialysis Transplantation · 27.09.2024 · 39 (10) · 1593-1603

DOI: 10.1093/ndt/gfae040 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Nephrology Dialysis Transplantation, online erschienen am 04.03.2024. Verfasst von Vianda S Stel und 29 weiteren Autor:innen. Beteiligte Einrichtung: ERA Registry, Department of Medical Informatics, Amsterdam UMC Location, University of Amsterdam, Amsterdam, the Netherlands. Hauptthemen laut MEDLINE: Registries, Renal Replacement Therapy. Die Arbeit wurde bisher 54-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: European Renal Association.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

This paper compares the most recent data on the incidence and prevalence of kidney replacement therapy (KRT), kidney transplantation rates, and mortality on KRT from Europe to those from the United States (US), including comparisons of treatment modalities (haemodialysis (HD), peritoneal dialysis (PD), and kidney transplantation (KTx)).

Methods

Data were derived from the annual reports of the European Renal Association (ERA) Registry and the United States Renal Data System (USRDS). The European data include information from national and regional renal registries providing the ERA Registry with individual patient data. Additional analyses were performed to present results for all participating European countries together.

Results

In 2021, the KRT incidence in the US (409.7 per million population (pmp)) was almost 3-fold higher than in Europe (144.4 pmp). Despite the substantial difference in KRT incidence, approximately the same proportion of patients initiated HD (Europe: 82%, US: 84%), PD (14%; 13%, respectively), or underwent pre-emptive KTx (4%; 3%, respectively). The KRT prevalence in the US (2436.1 pmp) was 2-fold higher than in Europe (1187.8 pmp). Within Europe, approximately half of all prevalent patients were living with a functioning graft (47%), while in the US, this was one third (32%). The number of kidney transplantations performed was almost twice as high in the US (77.0 pmp) compared to Europe (41.6 pmp). The mortality of patients receiving KRT was 1.6-fold higher in the US (157.3 per 1000 patient years) compared to Europe (98.7 per 1000 patient years).

Conclusions

The US had a much higher KRT incidence, prevalence, and mortality compared to Europe, and despite a higher kidney transplantation rate, a lower proportion of prevalent patients with a functioning graft.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RegistriesRenal Replacement TherapyHumansUnited StatesEuropeMaleFemaleIncidenceMiddle AgedPrevalenceKidney Failure, ChronicSurvival RateKidney TransplantationAdultPrognosisAged

Stichwörter der Autor:innen

epidemiologyincidencekidney replacement therapymortalityprevalence

Autor:innen und Institutionen

  • ERA Registry, Department of Medical Informatics, Amsterdam UMC Location, University of Amsterdam, Amsterdam, the Netherlands.
  • Amsterdam Public Health Research Institute, Quality of Care, Amsterdam, the Netherlands.
  • Clinical Center of Montenegro, Clinic for Nephrology, Podgorica, Montenegro.
  • Department of Medicine, Haukeland University Hospital, Bergen, Norway.
  • Department of Clinical Medicine, University of Bergen, Bergen, Norway.
  • Nephrology Department, Hospital Universitario Marqués de Valdecilla, University of Cantabria, IDIVAL, Santander, Cantabria, Spain.

ORCID-Profile: Brittany A Boerstra, Julia Kerschbaum, Kitty J Jager, Alberto Ortiz, Anneke Kramer

Förderung

  • European Renal Association

Zitieren

APA

Stel, V. S., Boenink, R., Astley, M. E., Boerstra, B. A., Radunovic, D., Skrunes, R., Ruiz San Millán, J. C., Slon Roblero, M. F., Bell, S., Ucio Mingo, P., Ten Dam, M. A. G. J., Ambühl, P. M., Resic, H., Rodríguez Arévalo, O. L., Aresté-Fosalba, N., Tort I Bardolet, J., Lassalle, M., Trujillo-Alemán, S., Indridason, O. S., …, & Kramer, A. (2024). A comparison of the epidemiology of kidney replacement therapy between Europe and the United States: 2021 data of the ERA Registry and the USRDS. Nephrology Dialysis Transplantation, 39(10), 1593-1603. https://doi.org/10.1093/ndt/gfae040

Vancouver

Stel VS, Boenink R, Astley ME, Boerstra BA, Radunovic D, Skrunes R, et al. A comparison of the epidemiology of kidney replacement therapy between Europe and the United States: 2021 data of the ERA Registry and the USRDS. Nephrology Dialysis Transplantation. 2024;39(10):1593-1603. doi:10.1093/ndt/gfae040

BibTeX
@article{Stel2024,
  author = {Stel, Vianda S and Boenink, Rianne and Astley, Megan E and Boerstra, Brittany A and Radunovic, Danilo and Skrunes, Rannveig and Ruiz San Millán, Juan C and Slon Roblero, Maria F and Bell, Samira and Ucio Mingo, Pablo and Ten Dam, Marc A G J and Ambühl, Patrice M and Resic, Halima and Rodríguez Arévalo, Olga Lucia and Aresté-Fosalba, Nuria and Tort I Bardolet, Jaume and Lassalle, Mathilde and Trujillo-Alemán, Sara and Indridason, Olafur S and Artamendi, Marta and Finne, Patrik and Rodríguez Camblor, Marta and Nitsch, Dorothea and Hommel, Kristine and Moustakas, George and Kerschbaum, Julia and Lausevic, Mirjana and Jager, Kitty J and Ortiz, Alberto and Kramer, Anneke},
  title = {A comparison of the epidemiology of kidney replacement therapy between Europe and the United States: 2021 data of the ERA Registry and the USRDS},
  journal = {Nephrology Dialysis Transplantation},
  year = {2024},
  volume = {39},
  number = {10},
  pages = {1593--1603},
  doi = {10.1093/ndt/gfae040}
}
Kostenlos starten →